Empagliflozin Market

Key Players

  • API Manufacturers
  • Accord Healthcare
  • Aurobindo Pharma
  • Aurobindo Pharma USA
  • Biogaran
  • Boehringer Ingelheim
  • Boehringer Ingelheim Pharmaceuticals
  • Boehringer Ingelheim UK
  • Bouchara-Recordati
  • Brand Owners
  • CSPC Pharmaceutical Group
  • Celltrion Pharm
  • Chong Kun Dang
  • Daewoong Pharmaceutical
  • Dong-A ST
  • Dr. Reddy’s Laboratories
  • Dr. Reddy’s Laboratories USA
  • Eli Lilly and Company
  • Eli Lilly Japan
  • Eli Lilly UK
  • Formulation
  • Hanmi Pharm. Co. Ltd
  • Hansoh Pharma
  • Hetero Labs
  • Hexal
  • Jiangsu Hengrui Pharmaceuticals Co. Ltd
  • Lupin
  • Lupin Pharmaceuticals
  • MSN Laboratories
  • MetroChem API
  • Nichi-Iko Pharmaceutical
  • Nippon Boehringer Ingelheim
  • Qilu Pharmaceutical
  • Ratiopharm
  • STADA Arzneimittel
  • L'Oréal
  • Sawai Group Holdings
  • Servier
  • Teva UK
  • Towa Pharmaceutical
  • Zentiva
  • Zentiva France
  • Zentiva Germany
  • Zentiva UK
  • Zhejiang Huahai Pharmaceutical
  • Zydus Lifesciences Ltd
Future Market Insights

Empagliflozin Market